Investigation of the Effect of the COVID-19 Pandemic Period on Respiratory Tract Viruses at Istanbul Medical Faculty Hospital, Turkey.

IF 3.4 Q2 INFECTIOUS DISEASES
Sevim Mese, Aytaj Allahverdiyeva, Mustafa Onel, Hayriye Kırkoyun Uysal, Ali Agacfidan
{"title":"Investigation of the Effect of the COVID-19 Pandemic Period on Respiratory Tract Viruses at Istanbul Medical Faculty Hospital, Turkey.","authors":"Sevim Mese, Aytaj Allahverdiyeva, Mustafa Onel, Hayriye Kırkoyun Uysal, Ali Agacfidan","doi":"10.3390/idr16050079","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> Respiratory viruses significantly impact public health, contributing to high morbidity and mortality rates in both children and adults. This study evaluates the distribution and incidence of respiratory tract viruses in our hospital from 2019 to 2022, focusing on changes post-COVID-19 pandemic. <b>Material and Methods:</b> Utilizing molecular methods, we analyzed nasopharyngeal swabs with the FTD Respiratory Pathogens 21 kit and the QIAStat Dx Respiratory Panel kit at Istanbul Faculty of Medicine. A total of 1186 viruses were detected in 2488 samples (47.6% of the total) examined with the FTD Respiratory Pathogens 21 kit between 2019 and 2022. <b>Results:</b> It was determined that the detection rates were 52.8% in 2019, 44.3% in 2020, 50.0% in 2021, and 40.0% in 2022. Notable changes in prevalence were observed for pandemic influenza A (IAV-H1N1pdm2009), parainfluenza virus (PIV)-3, rhinovirus (RV), and respiratory syncytial virus (RSV)-A/B (<i>p</i> < 0.05). RV consistently showed the highest detection rates across all years (17.6% to 7.9%). Additionally, 1276 viruses were detected in 1496 samples using the QIAStat DX kit, with 91.3% positivity in 2021 and 78.6% in 2022, highlighting the kit's effectiveness in rapid diagnosis. <b>Conclusions:</b> This study enhances understanding of respiratory virus epidemiology during and after the pandemic, emphasizing the need for ongoing surveillance and strategic public health measures to address the evolving landscape of respiratory infections.</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11507061/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Disease Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/idr16050079","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: Respiratory viruses significantly impact public health, contributing to high morbidity and mortality rates in both children and adults. This study evaluates the distribution and incidence of respiratory tract viruses in our hospital from 2019 to 2022, focusing on changes post-COVID-19 pandemic. Material and Methods: Utilizing molecular methods, we analyzed nasopharyngeal swabs with the FTD Respiratory Pathogens 21 kit and the QIAStat Dx Respiratory Panel kit at Istanbul Faculty of Medicine. A total of 1186 viruses were detected in 2488 samples (47.6% of the total) examined with the FTD Respiratory Pathogens 21 kit between 2019 and 2022. Results: It was determined that the detection rates were 52.8% in 2019, 44.3% in 2020, 50.0% in 2021, and 40.0% in 2022. Notable changes in prevalence were observed for pandemic influenza A (IAV-H1N1pdm2009), parainfluenza virus (PIV)-3, rhinovirus (RV), and respiratory syncytial virus (RSV)-A/B (p < 0.05). RV consistently showed the highest detection rates across all years (17.6% to 7.9%). Additionally, 1276 viruses were detected in 1496 samples using the QIAStat DX kit, with 91.3% positivity in 2021 and 78.6% in 2022, highlighting the kit's effectiveness in rapid diagnosis. Conclusions: This study enhances understanding of respiratory virus epidemiology during and after the pandemic, emphasizing the need for ongoing surveillance and strategic public health measures to address the evolving landscape of respiratory infections.

调查 COVID-19 大流行期间对土耳其伊斯坦布尔医学院附属医院呼吸道病毒的影响。
目的:呼吸道病毒严重影响公共卫生,导致儿童和成人的高发病率和高死亡率。本研究评估了 2019 年至 2022 年我院呼吸道病毒的分布和发病率,重点关注 COVID-19 大流行后的变化。材料和方法:利用分子方法,我们使用伊斯坦布尔医学院的 FTD Respiratory Pathogens 21 试剂盒和 QIAStat Dx Respiratory Panel 试剂盒对鼻咽拭子进行了分析。2019年至2022年期间,使用FTD Respiratory Pathogens 21试剂盒检测了2488份样本(占样本总数的47.6%),共检测出1186种病毒。结果:经测定,2019 年的检出率为 52.8%,2020 年为 44.3%,2021 年为 50.0%,2022 年为 40.0%。大流行性甲型流感(IAV-H1N1pdm2009)、副流感病毒(PIV)-3、鼻病毒(RV)和呼吸道合胞病毒(RSV)-A/B 的流行率出现了显著变化(P < 0.05)。在所有年份中,RV 的检出率一直最高(从 17.6% 到 7.9%)。此外,在使用 QIAStat DX 试剂盒的 1496 份样本中检测到了 1276 种病毒,其中 2021 年的阳性率为 91.3%,2022 年为 78.6%,突显了该试剂盒在快速诊断方面的有效性。结论这项研究加深了人们对大流行期间和之后呼吸道病毒流行病学的了解,强调了持续监测和战略性公共卫生措施的必要性,以应对不断变化的呼吸道感染形势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infectious Disease Reports
Infectious Disease Reports INFECTIOUS DISEASES-
CiteScore
5.10
自引率
0.00%
发文量
82
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信